Avenue Therapeutics Inc. buy Maxim Group
Start price
11.12.23
/
50%
€0.13
Target price
11.12.24
€0.70
Performance (%)
-16.72%
Price
25.04.24
€0.11
Summary
This prediction is currently active. The prediction for Avenue Therapeutics Inc. disappoints with a performance of -16.72%. This prediction currently runs until 11.12.24. The prediction end date can be changed by Maxim_Group at any time. Maxim_Group has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Avenue Therapeutics Inc. | - | - |
iShares Core DAX® | -0.552% | 3.405% |
iShares Nasdaq 100 | -1.415% | 4.613% |
iShares Nikkei 225® | -0.877% | -1.396% |
iShares S&P 500 | -0.415% | 3.338% |
Comments by Maxim_Group for this prediction
In the thread Avenue Therapeutics Inc. diskutieren
Avenue Therapeutics, Inc. (NASDAQ: ATXI) is now covered by analysts at Maxim Group. They set a "buy" rating and a $0.75 price target on the stock.
Ratings data for ATXI provided by MarketBeat